AIDS (London, England)
Point-of-care ultrasound guidance for long-acting cabotegravir-rilpivirine administration improves injection-site tolerability and preserves pharmacokinetics.
Sergio Padilla, Christian Ledesma, Marta Fernández-González, Fernando Pérez-Calvo, Melissa Bello-Perez, María Losada-Echeberría, Enrique Barrajón-Catalán, Javier García-Abellán, Paula Mascarell, Ángela Botella, Mar Masiá, Félix Gutiérrez
Published: 202510.1097/QAD.0000000000004437
Abstract
OBJECTIVE: Long-acting injectable cabotegravir + rilpivirine (CAB + RPV) streamlines HIV care but may be limited by injection-site reactions (ISRs) and pharmacokinetic (PK) variability. Point-of-care ultrasound (POCUS) can visualize tissue planes in…
Preview only. Read the full abstract at the source